S R Potter|A W Partin - JoVE Visualize

Showing results (41-50 of 228) with videos related to

Pageof 23

Sort By:

Seminars in Surgical Oncology|March 1, 1996

Role of laparoscopy in the diagnosis and treatment of prostate cancerR G Moore, A W Partin, L R Kavoussi

Reviews in Urology|September 21, 2006

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancerC R Pound, M K Brawer, A W Partin

Urology|September 1, 1995

Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh

Chromosoma|September 1, 1989

DNA loop domains in mammalian spermatozoaW S Ward, A W Partin, D S Coffey

Journal of Cellular Biochemistry. Supplement|June 5, 2001

Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterationsR W Veltri, A W Partin, M C Miller

Seminars in Urologic Oncology|September 19, 1998

Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigenT J Polascik, J D Pearson, A W Partin

The Journal of Urology|June 7, 2000

Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 diseaseM Han, P C Walsh, A W Partin, et al.

The American Journal of Surgical Pathology|March 1, 1996

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-upJ I Epstein, A W Partin, J Sauvageot, et al.

Cancer|April 20, 2001

Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinomaM Han, P B Snow, J M Brandt, et al.

The Journal of Urology|June 1, 1993

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followupJ I Epstein, M Carmichael, A W Partin, et al.

Pageof 23

Showing results (41-50 of 228) with videos related to

Sort By:

Pageof 23

Seminars in Surgical Oncology|March 1, 1996

Role of laparoscopy in the diagnosis and treatment of prostate cancerR G Moore, A W Partin, L R Kavoussi

Reviews in Urology|September 21, 2006

Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancerC R Pound, M K Brawer, A W Partin

Urology|September 1, 1995

Can aggressive prostatic carcinomas be identified and can their natural history be altered by treatment?D M Quinlan, A W Partin, P C Walsh

Chromosoma|September 1, 1989

DNA loop domains in mammalian spermatozoaW S Ward, A W Partin, D S Coffey

Journal of Cellular Biochemistry. Supplement|June 5, 2001

Quantitative nuclear grade (QNG): a new image analysis-based biomarker of clinically relevant nuclear structure alterationsR W Veltri, A W Partin, M C Miller

Seminars in Urologic Oncology|September 19, 1998

Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigenT J Polascik, J D Pearson, A W Partin

The Journal of Urology|June 7, 2000

Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 diseaseM Han, P C Walsh, A W Partin, et al.

The American Journal of Surgical Pathology|March 1, 1996

Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-upJ I Epstein, A W Partin, J Sauvageot, et al.

Cancer|April 20, 2001

Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinomaM Han, P B Snow, J M Brandt, et al.

The Journal of Urology|June 1, 1993

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followupJ I Epstein, M Carmichael, A W Partin, et al.

Pageof 23